Abstract:Immune responses against neuraminidase (NA) are of great interest for developing more robust influenza vaccines, but the role of anti-NA antibodies on influenza infectivity has not been established. We conducted household transmission studies in Managua, Nicaragua to examine the impact of anti-NA antibodies on influenza A/H3N2 susceptibility and infectivity. Analyzing these data with mathematical models capturing household transmission dynamics and their drivers, we estimated that having higher preexisting antibody levels against the hemagglutinin (HA) head, HA stalk, and NA was associated with reduced susceptibility to infection (relative susceptibility 0.67, 95% Credible Interval [CrI] 0.50-0.92 for HA head; 0.59, 95% CrI 0.42-0.82 for HA stalk; and 0.56, 95% CrI 0.40-0.77 for NA). Only anti-NA antibodies were associated with reduced infectivity (relative infectivity 0.36, 95% CrI 0.23-0.55). These benefits from anti-NA immunity were observed even among individuals with preexisting anti-HA immunity. These results suggest that influenza vaccines designed to elicit NA immunity in addition to hemagglutinin immunity may not only contribute to protection against infection but reduce infectivity of vaccinated individuals upon infection.

What problem does this paper attempt to address?

This paper discusses how antibodies against neuraminidase (NA) affect the transmission of human influenza virus A/H3N2. The study conducted transmission research in Nicaraguan households and used mathematical models to analyze the impact of antibody levels on susceptibility to infection and contagiousness. The study found that high concentrations of antibodies against HA head, HA stem, and NA were associated with reduced susceptibility to infection, but only antibodies against NA were significantly correlated with reduced contagiousness. This suggests that in addition to protecting against infection, designing influenza vaccines that induce NA immune responses may also reduce the ability of infected individuals to transmit the virus. These findings highlight the importance of NA as a target for vaccine development to reduce the transmission of influenza viruses in communities and provide indirect protection for unvaccinated or immunocompromised individuals.

Anti-Neuraminidase Antibodies Reduce the Susceptibility to and Infectivity of Influenza A/H3N2 Virus